Stem cells: Transplants on trial

Elie Dolgin
Additional contact information
Elie Dolgin: Elie Dolgin is a news editor with Nature Medicine.

Nature, 2011, vol. 480, issue 7377, S46-S47

Abstract: Stem-cell transplants are an important tool for treating myeloma. But with improved drug alternatives, doctors disagree about the best time to give the treatment.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/480S46a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:480:y:2011:i:7377:d:10.1038_480s46a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/480S46a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().